Even though direct studies on IDH1-mutant GSCs are limited, accumulating evidence suggests that both differentiated tumor cells and GSCs share this OXPHOS-centric metabolic profile, providing a common vulnerability. This evidence concerns the gene IDH1 and neoplasm.